Medicare Enrolled

Dr. Tobenna Nwizu, M.D.

Internal Medicine · Rowlett, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
7501 LAKEVIEW PKWY STE 100, Rowlett, TX 75088
9724122577
In practice since 2008 (18 years)
NPI: 1881879716 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nwizu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nwizu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nwizu

Dr. Tobenna Nwizu is an internal medicine in Rowlett, TX, with 18 years in practice. Based on federal Medicare data, Dr. Nwizu performed 79,595 Medicare services across 2,740 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nwizu received a total of $374,612 from 69 pharmaceutical and/or device companies across 639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nwizu is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 1% volume in TX$ $374,612 industry payments

Medicare Practice Summary

Medicare Utilization ↗
79,595
Medicare services
Top 1% in TX for internal medicine
2,740
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,422 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)49,470$0$5
Pembrolizumab injection (Keytruda)9,600$43$137
Denosumab injection (Prolia/Xgeva)6,660$18$66
Anti-nausea injection (fosaprepitant)4,500$0$5
Dexamethasone injection (steroid)2,114$0$1
Blood draw (venipuncture)951$8$20
Complete blood count (CBC) with differential921$8$36
Comprehensive metabolic blood panel750$10$64
Anti-nausea injection (Aloxi/palonosetron)470$1$114
Office visit, established patient (30-39 min)415$91$368
Office visit, established patient, complex (40-54 min)287$130$496
Iron level test275$6$27
Iron binding capacity test275$9$35
Ferritin level test (iron stores)274$13$60
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less257$21$157
Injection, carboplatin, 50 mg202$2$300
Administration of chemotherapy into vein, 1 hour or less188$96$707
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less148$48$313
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle145$53$211
Drug injection, under skin or into muscle143$11$96
Immunoglobulin level test141$9$56
Magnesium level test117$7$29
Injection of additional new drug or substance into vein103$12$108
Measurement of immunoglobulin light chains94$17$60
Infusion, normal saline solution , 1000 cc91$2$19
Injection, diphenhydramine hcl, up to 50 mg87$1$7
Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services85$70$70
Office visit, established patient (20-29 min)79$65$250
Administration of chemotherapy into vein, each additional hour73$21$161
Lactate dehydrogenase (enzyme) level72$6$31
Manual urinalysis test with examination using microscope, non-automated63$4$26
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour59$14$100
Carcinoembryonic antigen (cea) protein level58$18$99
Administration of additional new drug or substance into vein, 1 hour or less58$49$344
Infusion into a vein for hydration, each additional hour53$10$75
Complete blood count (CBC), automated47$6$34
New patient office visit (45-59 min)41$106$565
PSA test (prostate cancer screening)40$18$94
Unclassified drugs40$1$8
Infusion into a vein for hydration, 31-60 minutes33$23$256
New patient office visit (30-44 min)32$80$372
Reticulated (young) platelet measurement29$35$143
New patient office visit, complex (60-74 min)20$155$709
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries18$90$657
Nuclear medicine study from skull base to mid-thigh with ct scan17$1,169$4,802
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
63.0% high complexity
30.5% medium
6.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$374,612
Total received (2018-2024)
Avg $53,516/year across 7 years
Top 0% in TX for internal medicine
69
Companies
639
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$325,365 (86.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$38,969 (10.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,868 (2.4%)
Other
Charitable contributions, space rental, and other categories
$1,410 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$28,099
2023
$68,276
2022
$61,944
2021
$25,592
2020
$23,201
2019
$46,687
2018
$120,812

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$225,808
PFIZER INC.
$35,338
Eisai Inc.
$32,669
EISAI INC.
$28,672
Helsinn Therapeutics (U.S.), Inc.
$19,902
Global Blood Therapeutics, Inc.
$9,079
Exelixis Inc.
$4,213
CTI BioPharma Corp.
$2,789
Gilead Sciences, Inc.
$2,363
GlaxoSmithKline, LLC.
$2,174
Bayer HealthCare Pharmaceuticals Inc.
$1,800
Novartis Pharmaceuticals Corporation
$1,361
Rigel Pharmaceuticals, Inc.
$1,307
Daiichi Sankyo Inc.
$490
Sirtex Medical Inc
$468
E.R. Squibb & Sons, L.L.C.
$439
Incyte Corporation
$380
Janssen Biotech, Inc.
$357
Medtronic, Inc.
$341
Pharmacyclics LLC, An AbbVie Company
$316
Karyopharm Therapeutics Inc.
$274
NOVARTIS PHARMACEUTICALS CORPORATION
$250
Ipsen Biopharmaceuticals, Inc
$245
Merck Sharp & Dohme LLC
$242
Celgene Corporation
$200
Astellas Pharma US Inc
$194
Allergan Inc.
$173
Foundation Medicine, Inc.
$168
Pharmacyclics LLC, an AbbVie Company
$166
SOBI, INC
$139
Merck Sharp & Dohme Corporation
$139
DAVOL INC.
$135
PharmaEssentia USA Corporation
$127
Adaptive Biotechnologies Corporation
$111
Emmaus Medical, Inc.
$105
ABBVIE INC.
$99
Janssen Pharmaceuticals, Inc
$95
Heron Therapeutics, Inc.
$90
Jazz Pharmaceuticals Inc.
$87
Amgen Inc.
$82
Lilly USA, LLC
$81
Bayer Healthcare Pharmaceuticals Inc.
$78
Stemline Therapeutics Inc.
$75
Tempus AI, Inc
$74
Regeneron Healthcare Solutions, Inc.
$74
Myovant Sciences Inc.
$60
GENZYME CORPORATION
$60
ADC Therapeutics America, Inc.
$57
BeiGene USA, Inc.
$57
PUMA BIOTECHNOLOGY, INC.
$55
Pharming Healthcare, Inc.
$52
SHIELD THERAPEUTICS INC
$48
TerSera Therapeutics LLC
$46
Seagen Inc.
$39
Kyowa Kirin, Inc.
$39
MorphoSys, US Inc.
$38
Genentech USA, Inc.
$38
EMD Serono, Inc.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$32
Myriad Genetic Laboratories, Inc.
$32
Aveo Pharmaceuticals, Inc.
$29
Kite Pharma, Inc.
$29
ARRAY BIOPHARMA INC
$23
Mirati Therapeutics, Inc.
$17
Sun Pharmaceutical Industries Inc.
$15
Blueprint Medicines Corporation
$12
Epizyme, Inc.,
$12
Dendreon Pharmaceuticals LLC
$12
Tactile Systems Technology Inc
$11
Top 3 companies account for 78.4% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADAKVEO · ADCETRIS · AFINITOR · AKEEGA · AKYNZEO · ALLODERM · Alecensa · BESREMI · BLENREP · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · CINVANTI · Cabometyx · DARZALEX · Doptelet · ELAHERE · ELIQUIS · EMEND · ENHERTU · EPKINLY · ERLEADA · Endari · Enhertu · FLEXITOUCH · FOTIVDA · FOUNDATIONONE · Fabhalta · GAVRETO · IBRANCE · IMBRUVICA · IMFINZI · INFUGEM · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LENVIMA · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nplate · Nubeqa · OJJAARA · ONIVYDE · OPDIVO · ORGOVYX · OSTEOCOOL RF ABLATION · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · Orserdu · PADCEV · PHASIX · PLUVICTO · POTELIGEO · PRECISETUMOR · PROVENGE · Padcev · Pomalyst · PreciseTumor · Prolia · REBLOZYL · RYBREVANT · Rezlidhia · SANCUSO · SARCLISA · SIR-Spheres Microspheres · SOMATULINE DEPOT · STRATTICE · Stivarga · Sustol · TABRECTA · TAGRISSO · TALZENNA · TASIGNA · TAZVERIK · Tavalisse · Trodelvy · VENCLEXTA · VERZENIO · VONJO · Vanflyta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · YERVOY · ZEPZELCA · ZOLADEX · Zydelig · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in TX.

Equivalent to $471 per 100 Medicare services performed
Looking for a internal medicine in Rowlett?
Compare internal medicines in the Rowlett area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
1,762
Per 100K population
67.7
County median income
$74,149
Nearest hospital
BAYLOR SCOTT AND WHITE MEDICAL CENTER LAKE POINTE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nwizu is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (speaking/promotional, top 0%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Nwizu experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Nwizu performed 49,470 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nwizu receive payments from pharmaceutical companies?
Yes. Dr. Nwizu received a total of $374,612 from 69 companies across 639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nwizu's costs compare to other internal medicines in Rowlett?
Dr. Nwizu's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nwizu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →